Specificity of Anti-SSB As a Diagnostic Marker for the Classification of Systemic Lupus Erythematosus

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2013 Jul 10

PMID 23837059

Citations 9

Authors

Li Rao

Guiyan Liu

Chunfen Li

Yajuan Li

Zhiguo Wang

Zijiao Zhou

Shengquan Tong

Xianming Wu

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the sensitivity and specificity of anti-Sjögren's syndrome type B (SSB) antibodies for diagnosing systemic lupus erythematosus (SLE) and to understand the correlation between anti-SSB antibodies and the clinical manifestations of SLE. A line immunoassay (LIA) was used to detect the presence of serum anti-SSB antibodies in SLE patients. The clinical manifestations of the patients were recorded to enable their correlation with the serum anti-SSB antibodies to be analyzed. In 25.7% of the 74 SLE patients, the serum was positive for anti-SSB antibodies, whereas only 3.3% of the 30 control cases were positive. The specificity of anti-SSB antibodies for detecting SLE was 96.7%. In anti-SSB antibody-positive SLE patients, the incidence of cheek erythema, alopecia, serositis, secondary Sjögren's syndrome (sSS), leukocytopenia, elevated immunoglobulin (Ig)G and positive presence of anti-Sjögren's syndrome type A (SSA)60 or anti-SSA52 antibodies was higher than in the anti-SSB antibody-negative group (P<0.05). Anti-SSB antibodies are important for the diagnosis of SLE and are associated with cheek erythema, alopecia, serositis, sSS, leukocytopenia, the elevation of IgG and positive presence of anti-SSA60 or anti-SSA52 antibodies.

Citing Articles

Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus.

Gong M, Dai L, Xie Z, Hong D, Li N, Fan X Sci Rep. 2023; 13(1):10101.

PMID: 37344560 PMC: 10284812. DOI: 10.1038/s41598-023-37100-5.

Autoantibody Profile of Egyptian Juvenile Systemic Lupus Erythematosus Patients and Its Association with Clinical Characteristics and Disease Activity.

Teama M, El-Mohamdy M, Abdellah Abdullah Mahmoud F, Badr F Open Access Rheumatol. 2021; 13:201-212.

PMID: 34295197 PMC: 8291800. DOI: 10.2147/OARRR.S317315.

Association of Oxidative Stress with Disease Activity and Damage in Systemic Lupus Erythematosus: A Cross Sectional Study from a Tertiary Care Centre in Southern India.

Shruthi S, Thabah M, Zachariah B, Negi V Indian J Clin Biochem. 2021; 36(2):185-193.

PMID: 33867709 PMC: 7994501. DOI: 10.1007/s12291-020-00879-5.

Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjögren's Syndrome Correlate with Lupus Activity.

Wang A, Gu Z, Liao R, Shuai Z J Ophthalmol. 2019; 2019:8509089.

PMID: 31559092 PMC: 6735177. DOI: 10.1155/2019/8509089.

Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?.

Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F Front Immunol. 2018; 9:541.

PMID: 29632529 PMC: 5879136. DOI: 10.3389/fimmu.2018.00541.

References

Routsias J, Touloupi E, Dotsika E, Moulia A, Tsikaris V, Sakarellos C . Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med. 2002; 8(6):293-305. PMC: 2039996. View

Jeoung D, Lim Y, Lee E, Lee S, Kim H, Lee H . Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. J Autoimmun. 2004; 22(1):87-94. DOI: 10.1016/j.jaut.2003.10.009. View

Bombardier C, Gladman D, Urowitz M, Caron D, Chang C . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35(6):630-40. DOI: 10.1002/art.1780350606. View

Routsias J, Dotsika E, Touloupi E, Papamattheou M, Sakarellos C, Sakarellos-Daitsiotis M . Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun. 2003; 21(1):17-26. DOI: 10.1016/s0896-8411(03)00063-5. View

Pourmand N, Wahren-Herlenius M, Gunnarsson I, Svenungsson E, Lofstrom B, Ioannou Y . Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis. 1999; 58(10):623-9. PMC: 1752767. DOI: 10.1136/ard.58.10.623. View

Verstegen G, Duyck M, Meeus P, Ravelingien I, de Vlam K . Detection and identification of antinuclear antibodies (ANA) in a large community hospital. Acta Clin Belg. 2009; 64(4):317-23. DOI: 10.1179/acb.2009.049. View

Servais G, Guillaume M, Dumarey N, Duchateau J . Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus. Ann Rheum Dis. 1999; 57(10):606-13. PMC: 1752489. DOI: 10.1136/ard.57.10.606. View

Peene I, Meheus L, Veys E, de Keyser F . Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis. 2002; 61(12):1090-4. PMC: 1753972. DOI: 10.1136/ard.61.12.1090. View

Alspaugh M, Maddison P . Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration. Arthritis Rheum. 1979; 22(7):796-8. DOI: 10.1002/art.1780220719. View

10.

Barcellos K, Nonogaki S, Enokihara M, Teixeira M, Andrade L . Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome. J Rheumatol. 2007; 34(6):1283-92. View

11.

Hsieh S, Yu H, Lin W, Sun K, Tsai C, Huang D . Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol. 2003; 131(3):506-16. PMC: 1808654. DOI: 10.1046/j.1365-2249.2003.02084.x. View

12.

Biswas D, Mathias A, Dayal R, Aggarwal A, Misra R, Naik S . Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus. Clin Rheumatol. 2007; 27(6):717-22. DOI: 10.1007/s10067-007-0776-x. View

13.

Routsias J, Tzioufas A . B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun. 2010; 35(3):256-64. DOI: 10.1016/j.jaut.2010.06.016. View

14.

Peene I, Meheus L, Veys E, de Keyser F . Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis. 2001; 60(12):1131-6. PMC: 1753451. DOI: 10.1136/ard.60.12.1131. View

15.

. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999; 42(9):1785-96. DOI: 10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#. View

16.

Chen H, Guo J, Li Z . Significance of anti-cell membrane-associated DNA (mDNA) antibodies in systemic lupus erythematosus. Clin Rheumatol. 2007; 27(2):183-7. DOI: 10.1007/s10067-007-0675-1. View

17.

Riemekasten G, Marell J, Trebeljahr G, Klein R, Hausdorf G, Haupl T . A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest. 1998; 102(4):754-63. PMC: 508938. DOI: 10.1172/JCI2749. View

18.

Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16):1526-33. DOI: 10.1056/NEJMoa021933. View

19.

Tang F, Dong Y, Zhang N . Detection of anti-SSB antibodies in patients with rheumatic diseases. Chin Med Sci J. 1993; 8(1):55-8. View

20.

ter Borg E, Horst G, Hummel E, Limburg P, Kallenberg C . Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990; 33(5):634-43. DOI: 10.1002/art.1780330505. View